共 50 条
Outpatient drug safety: new steps in an old direction
被引:29
|作者:
Budnitz, Daniel S.
Layde, Peter M.
机构:
[1] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Coordinating Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Med Coll Wisconsin, Injury Res Ctr, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Hlth Policy Inst, Milwaukee, WI 53226 USA
关键词:
outpatients;
drug therapy;
safety;
quality of healthcare;
ambulatory care;
accident prevention;
adverse effects;
D O I:
10.1002/pds.1242
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
Iatrogenic injury from adverse drug events (ADEs) is a common and often preventable problem in modem medical practice. Attention to this problem has focused on the inpatient hospital setting and healthcare professionals. However, most medication is prescribed and used outside of hospitals and is managed by patients or lay caregivers in homes or workplaces. To address the public health problem of outpatient drug safety, interventions to prevent adverse events must recognize the central role of the patient in medication management and environmental factors specific to the outpatient setting. Lessons and techniques from the field of injury prevention should guide the development and implementation of safety interventions. First, Haddon's phase-factor matrix can be used to help conceptualize outpatient drug safety interventions. Second, interventions to improve outpatient drug safety should be patient-centered and extend beyond patient education to include engineering innovations and enforcement strategies. Third, the sustainability of active versus passive interventions should be considered when choosing safety interventions. Published in 2006 by John Wiley & Sons, Ltd.
引用
收藏
页码:160 / 165
页数:6
相关论文